With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

A study found that undergoing a cardiac ablation procedure first—before taking any antiarrhythmic therapies—may be the better ...

From its cardiovascular divisions, Medtronic brought in $3.1 billion for an increase of 6.1%—driven in part by the launches ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for ...

Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure ...

For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved ...

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...

The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent ...

Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...